May 06, 2024 9:05am EDT Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
Apr 30, 2024 3:40pm EDT Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance
